Israel-based startup OncoHost, the developer of a blood test to predict how well cancer patients will react to treatment, said it will collaborate with the National Health Service (NHS) to set up eight clinical trial sites in the United Kingdom.
Read more here.
![[Corelight in Gov Info Security] Corelight’s Brian Dye on NDR’s Role in Defeating Ransomware](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
